Penn Pharma provides drug development and manufacturing services for more than 150 healthcare companies in Europe, Japan and America. It also supplies services for clinical trials, such as drug labelling, packing and distribution, and it recently opened a manufacturing plant for potent compounds in South Wales. Under chief executive Richard Yarwood, 59, Penn’s international sales reached £39m in 2013.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.
